Solution structure of an antimicrobial peptide buforin II  by Yi, Gwan-Su et al.
FEBS 17799 FEBS Letters 398 (1996) 87-90 
Solution structure of an antimicrobial peptide buforin II 
Gwan-Su YP, Chan Bae Park b, Sun Chang Kim b, Chaejoon Cheong ~* 
~Magnetic Resonance Group, Korea Basic Science Institute, 52 Yeoeun-Dong, Yusung-Gu, Taejon 305-333, South Korea 
t'Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Taejon 305-701, South Korea 
Received 23 July 1996; revised version received 1 October 1996 
Abstract The structure of 21-residue antimicrobial peptide 
buforin II has been determined by using NMR spectroscopy and 
restrained molecular dynamics. Buforin II adopts a flexible 
random structure in H20. In trifluoroethanol (TFE)/H20 (1 : 1, 
vlvi mixture, however, buforin II assumes a regular m-helix 
between residues Va112 and Arg 2° and a distorted helical 
structure between residues Gly 7 and Pro n. The model structure 
obtained shows an amphipathic haracter in the region from Arg 5 
to the C-terminus, Lys 2z. Like other known cationic antimicro- 
bial peptides, the amphipathic structure might be the key factor 
for antimicrobial activity of buforin II. 
A7 ,J words: Antimicrobial  peptide; Buforin II; 2D-NMR;  
M,,lecular dynamics 
1. Introduction 
(ecently,  an antimicrobial peptide, buforin I, was isolated 
fr~ m the stomach tissue of an Asian toad, Bufo bufo garga- 
riz ms, and a more potent peptide buforin II was derived from 
bul'orin I [1]. These peptides how strong antimicrobial activ- 
i tks in vitro against a broad spectrum of microorganisms, 
imluding fungi [1]. Buforin II, a 21-residue cationic peptide 
co l ta in ing the residues from Thr  16 to Lys 36 of buforin I, 
sh,)ws about two times higher activity than buforin I. 
Fhere have been comprehensive studies on a cationic anti- 
microbial peptide, magainin 2, isolated from the skin of Xe- 
no ~us laevis [2]. Magainin 2 forms an e~-helix in trif luoroetha- 
nc I (TFE) /H20 with charged residues on one side resulting in 
a arge hydrophobic moment  [3]. It interacts with bacterial 
a~.:l acidic model membranes [4] and destroys the ionic gra- 
dient across the cell membranes by forming ion channels [5]. 
F, r the buforin peptides, the structure and the detailed mech- 
awtsm of the activity have not been resolved yet. Because the 
pr mary sequences of buforin II and magainin 2 are very 
diI 'erent and the antimicrobial activities of buforin 2 are 
at-out 20 times higher than those of magainin 2, the structure 
ol buforin II is of interest. 
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Ai breviations: TFE, trifluoroethanol; DQF-COSY, double quantum 
filtered correlation spectroscopy; TOCSY, total correlation spectros- 
co ~)y; NOESY, nuclear Overhauser enhancement spectroscopy; TPPI, 
time-proportional phase incrementation; RMD, restrained molecular 
dynamics; SA, simulated annealing; NOE(s), nuclear Overhauser 
effect(s) 
2. Experimental 
2.1. Peptide synthesis 
Buforin II was synthesized by the Seoul Branch of the Korea Basic 
Science Institute (KBSI), using the solid-phase synthesis method on a 
Milligen 9050 Pepsynthesizer and fluoren-90-ylmethoxycarbony(F- 
moc)-polypeptide active ester chemistry. The product was purified 
by reverse-phase HPLC on a Waters Delta-pak C18 column. The 
peptide was eluted with a H20/acetonitrile linear gradient containing 
0.1% trifluoroacetic acid. The homogeneity was assessed by the re- 
verse-phase HPLC on a Waters Delta-pak C18 column and by amino 
acid analysis on a Waters PICO-TAG ~ Amino Acid Analysis System. 
Its mass was confirmed on a Kratos MALDI-TOF spectrometer by 
the Mass Spectrometry Group at KBSI. 
2.2. NMR spectroscopy 
The NMR spectra were obtained on a Bruker DMX600 spectrom- 
eter. The samples were either in 50 mM phosphate buffer containing 
10% D20 at pH 7.0 or in TFE-d3/50 mM phosphate buffer at pH 7.0 
(l : 1, by volume). The concentration f the peptide was about 2 mM 
and the experiments were performed at 10°C, 25°C and 35°C. Deut- 
crated solvents were purchased from Aldrich and Cambridge Isotope 
Laboratory. For sequential ssignments and structural determination, 
double quantum filtered correlation spectroscopy (DQF-COSY) [6], 
total correlation spectroscopy (TOCSY) [7] and nuclear Overhauser 
enhancement spectroscopy (NOESY) [8] experiments were performed. 
In TOCSY experiments, an MLEV-17 composite pulse sequence [9] 
was used for spin locking with a mixing time of 75 ms. The NOESY 
spectra were obtained with mixing times from 50 to 300 ms. Nor- 
mally, the 2D data were acquired with 2 k (t2 domain) ×512 (tl 
domain) data points, but for the DQF-COSY, 4 k x 1 k data points 
were collected. 
2.3. Structure calculation 
Structures of buforin II were calculated using a molecular modeling 
program, NMRchitect (Biosym, Inc.) on an Indigo2 (Silicon Gra- 
phics, Inc.) workstation and a Cray Y-MP C916/16512 supercomputer 
in the System Engineering Research Institute (Taejon, Korea). Sixty- 
nine distance constraints for the structure calculations were obtained 
from the NOESY spectra cquired in TFE/H20 at pH 7, 10°C. Vol- 
ume integration was performed for NOESY mixing times of 50, 100, 
150 and 250 ms and the crosspeak intensities were classified as strong, 
medium, or weak and converted into upper bounds of distance re- 
straints of 2.8, 3.6 or 5.0 A, respectively. The 12 JHNc~ values were 
converted into loose dihedral angle restraints of -30 ° < ~ < - 100 °. 
Hydrogen bonding restraints were not used. Thirty initial structures 
were generated and refined using the distance geometry algorithm [10] 
DGII (Biosym, Inc.) with the NMR restraints. 
The best structure which showed the lowest violation against he 
constraints was subjected to the restrained molecular dynamics 
(RMD) with the simulated annealing (SA) procedure [11] of NMRchi- 
tect (Biosym, Inc.). The consistent valence force field (CVFF) of DIS- 
COVER 2.9 (Biosym, Inc.) was used for the molecular dynamics 
calculations. The SA procedure was started by restrained energy mini- 
mization which includes 100 iterations using the steepest descent mini- 
mization followed by 500 iterations using the conjugate gradients 
minimization. Then, 0.5 ps of RMD with 1 fs time steps was per- 
formed at 300 K followed by energy minimization. After this, the 
temperature was raised to 1000 K and the RMD was performed for 
50 ps. Then, the temperature was gradually lowered to 300 K by 10 ps 
RMD in 5 steps. Finally, the steepest descent (100 iterations) and 
subsequent conjugate gradient minimizations (1500 iterations) were 
performed twice. 
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Fig. 1. NH/NH region of the NOESY spectrum of buforin II in 
TFE/H20 (1 : 1, by volumes). The mixing time was 250 ms. 
3. Results 
The chemical shifts of buforin II have been assigned accord- 
ing to the standard assignment methods [12] using DQF- 
COSY, TOCSY and NOESY (Table 1). 
Structural information of buforin II in TFE/H20 was ob- 
tained from NOESY and DQF-COSY data. Fig. 1 shows the 
sequential NH(i)/NH(i+I) NOEs of buforin II in TFE/H20, 
which is a typical evidence of a helical conformation [12]. But, 
none of intense crosspeaks appears in the H20 spectrum (data 
not shown). The sequential NH(i)/NH(i+I) NOEs appear in 
the region from Arg 5 to Arg 2° (Figs. 1 and 2). Fig. 2 shows a 
summary of the NMR data acquired in TFE/H20. We find 
characteristic NOE connectivities indicative of helical struc- 
ture in the region from Gly 7 to Arg 2°. These connectivities 
include such as ~H(i)/NH(i+3), aH(i)/NH(i+4), all(i)/ 
I]H(i+3), [~H(i)/NH(i+I) and NH(i)INH(i+2) NOEs. The 
most dense region of NOE connectivities i  between Pro m 
and Leu is. We conclude that the overall structure of the re- 
gion from Gly 7 to Arg 2° is helical with the most stable region 
ranging from Pro u to Leu is. 
Although the overall conformation of the GlyT-Arg 2° seg- 
ment is helical, there should be a distortion around Pro n 
residue. The NOEs of 8H(i)/NH(i+ 1) and [~H(i)/NH(i+ 1) be- 
tween Pro u and Va112 are weak. In addition, the aH chemical 
shifts of Phe 1° and Pro u are not those of the standard a-helix 
[13,14]. The aH resonances normally shift upfield when the 
conformation changes from random coil to a-helix [13,14]. 
The aH chemical shifts of the C-terminal half region 
(Val12-Lys21) are shifted upfield as expected for a-helical ge- 
ometry. However, the chemical shifts of Phe ~° and Pro n are 
shifted downfield. From the NOE connectivities and aH 
chemical shift data, we think that the backbone geometry 
near Pro u is distorted into extended conformation. 
This conformational distortion does not mean that the helix 
terminated atPro u. In the NOE and JHN~ analysis, the effects 
of Pro n are not great. Some of the medium range connectiv- 
ities indicative of the helical conformation such as NH(i)/ 
NH(i+2), aH(i)/NH(i+3) and ~H(i)/NH(i+I) NOEs extend 
over this region (Fig. 2). Therefore, we conclude that the 
changes in the chemical shifts near Pro m are due to a local 
disturbance of the helix by the proline residue. This conclu- 
sion is not unique; there are several reports that a-helices can 
be extended over a proline residue [15,16]. Some reports sug- 
gest that the termination of the a-helical structure should 
depend on the interaction between the helical-end residue 
and the side chain groups of the neighboring residues [17,18]. 
From the NMR data, we conclude that the GlyT-Arg 2° 
segment is in a helical structure with a regular a-helix between 
Va112 and Arg 2° and a distortion between Phe 1° and Va112. 
The smaller number of medium range connectivities in the 
GlyT-Phe 1° region shows that this region is more flexible 
than the C-terminal a-helix. 
Based on the NMR data, we built a molecular model of 
buforin II in TFE/H20. Forty conformers were generated by 
SA starting from the DG structure. We selected eight confor- 
mers as the final converged structures; the others had higher 
conformational energy or too many constraint violations (Fig. 
3). The distance violations for these eight conformers are less 
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Fig. 2. Summary of the sequential nd medium-range connectivities and some scalar coupling constants (JHNa) for buforin II in TFE/H20. The 
strength of the observed NOEs is represented by the thickness of bars. The dashed line or dashed box represents he NOEs from the over- 
lapped crosspeaks. For the connectivities of Pro 11, the 8H was used instead of the NH. 
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th~n 0.16 * and their RMSDs are 2.28 ,~ for all atoms and 
1.33 ,~ for the backbone atoms. As was expected from the 
NMR data, the conformers how a regular a-helix between 
Va112 and Arg 2°. The distortion starts at Va112. The average 
dihedral angle connecting Pro 11 and Va112 is -103+11 ° 
whereas that of a regular c~-helix is -57  °. The GlyT-Va112 
se~,ment is composed of one and a half turns of helix. The 
di~ meter of this helix ( 5.62 ,~) is same as that of n-helix but 
its pitch (-6.82 A) is larger than that of either a n-helix (4.73 
or an ~-helix (5.4 A). 
V15 
L8 
L19 
V12 
V12 L8  L19  
89 
4. Discussion P l l  
FEF is known to have a propensity to promote helix struc- 
tu e .  But recent studies have shown that any peptide cannot 
be.-ome helical in TFE  [19,20] and that it acts only within the 
cc, ntext of a preexisting helix-coil equil ibrium [21] rather than 
it creates a helix structure. This peptide does not exist as a 
sfigle conformation even in 50% TFE. The JHNc~ values (Fig. 
2) represent averaged values of conformational  ensembles. So, 
th ~ structure that we present here should be regarded as one 
ol the highly populated conformational  states of buforin lI in 
sciution. 
Because the sequence of buforin II is a part of the N-ter- 
m nus of Xenopus histone H2A, the histone octamer structure, 
d~termined by X-ray crystallography [22], provides a good 
c< mparison. In the histone H2A structure, the region corre- 
st 'onding to the C-terminal half  region (Va112 to Lys 21) and 
a lout  five residues from the N-terminus of buforin II are c~- 
ht lical [22]. The region corresponding to the C-terminal half 
re; ion of buforin II is a part of the helix loop-helix type 
st ucture element in histone octamer. Combined with our re- 
sl it ,  we conclude that the C-terminal region of buforin II 
r~ :ains the tendency to form an c~-helix even in the amphiphi-  
1 c:g. 3. Stereoview of the backbone atoms of the eight final struc- 
ttres of buforin lI. The restraints for the structure calculations were 
ol~tained from the NMR data in TFE/H20 at pH 7, 10°C. 
L18 ~ F10 
F10 
Fig. 4. The placement of hydrophobic residues of buforin lI in a 
regular c~-helix modcl (outer circle) and in the helical structure of 
our result (inner circle). The thick lines represent the hydrophobic 
region. 
lic environment. On the other hand, the N-terminal half of 
this peptide seems to have various structural possibilities de- 
pending on the environment. Not ing that the C-terminal half 
region of buforin II is a part of DNA binding moti f  of histone 
H2A, it is possible that a direct buforin DNA interaction 
might contribute to its antimicrobial activity. 
Table 1 
NMR assignment of buforin II 
ture 
in H20/TFE (1 : 1, by volume) mix- 
Residues Chemical shift (ppm) ~L 
HN H ~ H 13 Others 
Thr-l 8.16 4.30 4.45 HY 1.45 
Arg-2 7.38 4.42 1.90, 1.98 H "t 1.75; H a 3.25; 
NH 7.51, 6.72 
Ser-3 8.52 4.51 3.89, 4.00 
Ser-4 8.41 4.51 3.93, 4.03 
Arg-5 8.40 4.36 1.85. 1.97 H e 1.69, 1.75; H a 3.21; 
NH 6.10, 7.39 
Ala-6 8.10 4.30 
Gly-7 8.19 3.98 
Leu-8 7.81 4.35 
Gln-9 8.13 4.34 
Phe-10 8.05 4.89 
1.47 
1.73 H Y 1.60; H a 0.91, 0.98 
1.98, 2.09 HV 2.28, 2.33; NH 6.71, 7.37 
3.09, 4.16 2,6H 7.29; 3.5H 7.34; 
4H 6.707 
Pro-ll 4.53 2.07, 2.19 H v 1.99, 2.04: H a 3.45, 3.79 
Val-12 7.68 3.86 2.06 H v 0.97, 1.04 
Gly-13 8.29 3.98, 4.01 
Arg-14 7.91 4.21 1.93 H e 1.65, 1.76; H a 3.18; 
NH 7.29 
Val-15 7.88 3.80 2.16 H e 0.94, 1.03 
His-16 8.18 4.39 3.24 2H 8.03; 4H 7.08 
Arg-17 7.93 4.19 1.97 H e 1.70, 1.77; H a 3.24; 
NH 7.43, 6.70 
Leu-18 8.10 4.28 1.89 H ~ 1.68; H a 0.92 0.95 
Leu-19 7.87 4.34 1.80 H e 1.56; H a 0.88 
Arg-20 7.78 4.29 1.89, 1.96 H v 1.68; H a 3.21; NH 7.26 
Lys-21 7.77 4.23 1.91 H e 1.47: H a 1.76; H ~ 3.04 
~Chemical shifts were referenced to 3-(trimethylsilyl) propionic acid 
resonance. The estimated error was _+0.01 ppm. 
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As shown in the helical wheel diagram (Fig. 4), buforin II 
forms an amphipathic helical structure. For magainins [4,5] 
this geometry is considered the key factor for the formation of 
transmembrane pores, which will lead to cell death. In the 
regular c~-helical geometry, amphipathic region of buforin II 
is limited to residues Pro 11 to Lys 21 (Fig. 4). The N-terminal 
half (Thr I to Phe 1°) cannot make an amphipathic alignment 
in the a-helical geometry. In our results, however, the amphi- 
pathic region is extended to the residues involving Arg 5 
through Lys 21 due to the unusual helical conformation of 
Ala6-Va112 segment. 
Even though buforin II may interact with biological mem- 
branes like magainins, the mechanism of membrane interac- 
tion may be different. The length of the amphipathic region of 
buforin II (from Arg 5 to Lys 21) is about 24 ~, which is about 
two-thirds of magainin 2 (35 ,~). Because the amphipathic 
region of buforin II cannot span the whole biological mem- 
brane (> 30 ,~ for the hydrophobic region), the ion channel 
model suggested for magainin 2 [5] cannot be directly applied 
to buforin II. Further studies are needed to elucidate the 
antimicrobial ctivities of buforins. 
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